Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.

Explorateur d’archives

Parcourir et rechercher des captures

Note importante

Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.

Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.

Parcourir les sites archivés

Parcourir toutes les sources →

Revised Fee Proposal for Drugs and Medical Devices May 24, 2018 (PDF - Version) Table of Contents Executive Summary Section I: Introduction Section II: Consultation Process Section III: Health Canada’s Response Fee Setting Costing Annual Fee Adjustment Small Business and…

Priority Review of Drug Submissions Policy (PDF Version - 97 K) Contact: Policy Bureau Enquiries Notice - Administrative Corrections to Health Canada's Priority Review Documents February 6, 2009 Our file number: 09-101263-867 Administrative changes were made to the French and…

Pre-Clinical Trial Application (CTA) Consultation Meeting Health Canada invites sponsors to request a pre- CTA consultation meeting. Such consultations may be particularly useful for new active substances or applications that will include complex issues that may be new to Health…

Canada’s regulatory approach to drugs for rare diseases: our role in bringing drugs to patients From Health Canada Canada's regulatory approach Clinical trials: apply and register Find a clinical trial Find drug reviews and decisions About orphan drugs and rare diseases Our role…

About drugs and rare diseases in Canada - Canada.ca

Health CanadaCaptures 12Dernière capture 11 avr. 2026en

About drugs and rare diseases in Canada From Health Canada Canada's regulatory approach Clinical trials: apply and register Find a clinical trial Find drug reviews and decisions About orphan drugs and rare diseases Our role in bringing drugs to patients About orphan drugs and…

Canada’s regulatory approach to drugs for rare diseases: find drug reviews and decisions From Health Canada Canada's regulatory approach Clinical trials: apply and register Find a clinical trial Find drug reviews and decisions About orphan drugs and rare diseases Our role in…

Canada’s regulatory approach to drugs for rare diseases: find clinical trials From Health Canada Canada's regulatory approach Clinical trials: apply and register Find a clinical trial Find drug reviews and decisions About orphan drugs and rare diseases Our role in bringing drugs…

Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trials From Health Canada Canada's regulatory approach Clinical trials: apply and register Find a clinical trial Find drug reviews and decisions About orphan drugs and rare diseases Our role…

Licences, authorizations and registrations for drug and health products Information on applying for licences, drug submission requirements, clinical trials and selling veterinarian drugs. Services and information Clinical Trials Database Browse this database for information on…

Consultation on Proposed Regulations Amending the Medical Devices Regulations (Post-market Surveillance) From Health Canada Current status: Closed This consultation ran from June 15, 2019 to August 26, 2019. You are invited to provide your input on the proposed Regulations…

Page 4239 sur 6399Affichage de 42381 à 42390 sur 63986

Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.